Abbisko Cayman Limited
€1.41
0
-€0.04-2.76% Today
Statistics
Day High
1.41
Day Low
1.41
52W High
1.95
52W Low
0.8
Volume
-
Avg. Volume
-
Mkt Cap
958.95M
P/E Ratio
146
Dividend Yield
-
Dividend
-
Upcoming
Earnings
2MarExpected
Expected EPS
-0.047663321472
Actual EPS
-0.052551867264
Financials
23.63%Profit Margin
Profitable221.63MRevenue
52.36MNet Income
People Also Follow
This list is based on the watchlists of people on Stock Events who follow 8ZD.F. It's not an investment recommendation.
Competitors
This list is an analysis based on recent market events. It's not an investment recommendation.
About
Abbisko Cayman Limited, a clinical-stage biopharmaceutical company, discovers and develops small molecule oncology therapies in Mainland China. The company's product candidates are primarily small molecules that focus on small molecule precision oncology and small molecule immuno-oncology therapeutic areas. It is also involved in the research and development in areas of biomedical and biotechnology; and provision of technical and technical consultation services. Abbisko Cayman Limited has co-discovery collaboration agreement with Eli Lilly and Company for the discovery, development, and commercialization of novel molecules; and BeiGene, Ltd. on the combination therapy of ABSK091 and tislelizumab, an anti-PD-1 antibody for treating urothelial cancer with FGFR2/3 genetic alterations, as well as a licensing agreement with Sperogenix (Shanghai) MedTech Co., Ltd. to develop and commercialize ABSK021 for indications in non-oncology neurological rare diseases. The company was founded in 2016 and is headquartered in Shanghai, the People's Republic of China.
Show more...
CEO
Dr. Yao-Chang Xu
Employees
226
Country
Cayman Islands
ISIN
KYG0028A1085
WKN
000A3C4Y0
Listings
0 Comments
Share your thoughts
FAQ
What is Abbisko Cayman Limited stock price today?▼
The current price of 8ZD.F is €1.41 EUR — it has decreased by -2.76% in the past 24 hours. Watch Abbisko Cayman Limited stock price performance more closely on the chart.
What is Abbisko Cayman Limited stock ticker?▼
Depending on the exchange, the stock ticker may vary. For instance, on exchange Abbisko Cayman Limited stocks are traded under the ticker 8ZD.F.
Is Abbisko Cayman Limited stock price growing?▼
8ZD.F stock has fallen by -6.62% compared to the previous week, the month change is a +6.82% rise, over the last year Abbisko Cayman Limited has showed a +68.86% increase.
What is Abbisko Cayman Limited market cap?▼
Today Abbisko Cayman Limited has the market capitalization of 958.95M
When is the next Abbisko Cayman Limited earnings date?▼
Abbisko Cayman Limited is going to release the next earnings report on August 18, 2026.
What were Abbisko Cayman Limited earnings last quarter?▼
8ZD.F earnings for the last quarter are -0.05 EUR per share, whereas the estimation was -0.05 EUR resulting in a -10.26% surprise. The estimated earnings for the next quarter are N/A EUR per share.
What is Abbisko Cayman Limited revenue for the last year?▼
Abbisko Cayman Limited revenue for the last year amounts to 221.63M EUR.
What is Abbisko Cayman Limited net income for the last year?▼
8ZD.F net income for the last year is 52.36M EUR.
How many employees does Abbisko Cayman Limited have?▼
As of April 29, 2026, the company has 226 employees.
In which sector is Abbisko Cayman Limited located?▼
Abbisko Cayman Limited operates in the Health & Wellness sector.
When did Abbisko Cayman Limited complete a stock split?▼
Abbisko Cayman Limited has not had any recent stock splits.
Where is Abbisko Cayman Limited headquartered?▼
Abbisko Cayman Limited is headquartered in Shanghai, Cayman Islands.